TP53 and small cell lung carcinoma: Additionally, the suppression of the CCT5 gene modified the responsiveness of small-cell lung cancer to chemotherapy45, and an increase in CCT5 expression has been correlated with decreased sensitivity of breast cancer cells to doxorubicin in instances involving p53 mutations46.